As the UK government publishes the latest in a succession of guidance documents on how Brexit will affect the supply of medicines – with a particular focus on preparations for a ‘no deal’ Brexit – the British Generic Manufacturers Association’s (BGMA’s) position on Brexit is clear.
“While we welcome the government’s efforts to help ensure that patients continue to receive their medicines in the case of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?